FDA Extends Comment Period for Draft Guidance on Remanufacturing of Medical Devices

Summary

The Food and Drug Administration (FDA) is extending the comment period for its draft guidance on remanufacturing medical devices, following a request from industry stakeholders for additional time to submit comments, in response to a notice of availability published in the Federal Register on June 24, 2021.